Conexeu Sciences Inc. (CNXU) shareholders
Close on Nov 18, 2026Market cap $66.43MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Multi-Valor AIF Umbrella Fund SICAV Quintus Growth Fund | 4,400,305 | 9.99% | 13G (passive) | May 21, 2026 |
| OnePointTwo Capital Performance LLC Joint filing with Purcell Lynn Sebastian (12.30%) | 3,359,240 | 12.30% | 13G (passive) | Jun 30, 2026 |
| Wright Michael G. | 3,276,643 | 12.10% | 13G (passive) | Jun 30, 2026 |
| David Bogart | 2,293,750 | 8.10% | 13G (passive) | Jun 30, 2026 |
| OnePointTwo Capital Ventures LLC | 1,875,000 | 6.80% | 13G (passive) | Jun 30, 2026 |
| Paisley Capital Holdings Corp | 1,800,000 | 6.70% | 13G (passive) | Jun 30, 2026 |
| Jeffrey Sharpe | 1,500,000 | 5.20% | 13D (active) amendment | Sep 14, 2026 |
| OnePointTwo Capital Ventures II LLC | 1,484,240 | 5.50% | 13G (passive) | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CNXU | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| UBS Group AG | 12,264 | 0.04% | $133.92K | New | 0.00% |
| Morgan Stanley | 5,871 | 0.02% | $64.11K | New | 0.00% |
| Citigroup Inc | 5,219 | 0.02% | $56.99K | New | 0.00% |
| Hollencrest Capital Management | 1,000 | 0.00% | $10.92K | New | 0.00% |
| Royal Bank of Canada | 887 | 0.00% | $10.00K | New | 0.00% |
| Integrated Wealth Concepts LLC | 400 | 0.00% | $4.37K | New | 0.00% |
| Osaic Holdings, Inc. | 100 | 0.00% | $1.09K | New | 0.00% |
| Jones Financial Companies Lllp | 100 | 0.00% | $1.10K | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 8 | 0M | 0.1% | 8 / 0 | 0 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| David Robert Bogart | Chief Commercial Officer, Director | 2,243,750 | 7.95% | Sep 28, 2026 |
| Miles David Harrison | President and CEO, Director | 237,861 | 0.84% | May 11, 2026 |
| Claudia Itze Chavez-Munoz | Chief Science Officer | 444,111 | 1.57% | May 11, 2026 |
| Stephen Douglas Inouye | CFO, Secretary, and Treasurer | 57,525 | 0.20% | May 11, 2026 |
| Brian Keith Pilcher | Chief Medical Officer | 87,861 | 0.31% | May 11, 2026 |
| Lynn Sebastian Purcell | Director, 10% owner | 3,118,514 | 11.06% | Oct 19, 2026 |
| Jeffrey Nathan Sharpe | Director | 1,500,000 | 5.32% | Sep 15, 2026 |
| Andrew Costa | Director | – | – | Jun 29, 2026 |
| April Lynn Burke | Director | – | – | Jun 24, 2026 |
| Ana Lucia Bastiani-Posner | Director | – | – | Jun 23, 2026 |
| Zbigniew Paul Lorenc | Director | 433,323 | 1.54% | May 15, 2026 |
| Aaron Solomon Farberg | Director | 10,869 | 0.04% | May 11, 2026 |
| Michael G. Wright | 10% owner | 2,898,048 | 10.27% | Jun 22, 2026 |
| Capital Ventures LLC OnePointTwo | 10% owner | 1,047,500 | 3.71% | May 14, 2026 |
| Capital Ventures II LLC OnePointTwo | 10% owner | 1,484,240 | 5.26% | May 11, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Lynn Sebastian Purcell Director, 10% owner | Oct 15, 2026 | Buy | +166,666 | $3.00 | $500.00K | 3,118,514 |
| David Robert Bogart Chief Commercial Officer, Director | Sep 25, 2026 | Option exercise | +750,000 | – | – | 1,812,500 |
| Jeffrey Nathan Sharpe Director | Sep 14, 2026 | Option exercise | +500,000 | – | – | 1,500,000 |
| Lynn Sebastian Purcell Director, 10% owner | Sep 4, 2026 | Option exercise | +217,608 | $2.30 | $500.50K | 2,951,848 |
| Lynn Sebastian Purcell Director, 10% owner | Sep 4, 2026 | Option exercise | +217,608 | $2.30 | $500.50K | 2,951,848 |
| Lynn Sebastian Purcell Director, 10% owner | Jun 18, 2026 | Buy | +202,500 | $0.80 | $162.00K | 2,734,240 |
| Michael G. Wright 10% owner | Jun 18, 2026 | Option exercise | +250,000 | – | – | 2,148,048 |
| Michael G. Wright 10% owner | May 26, 2026 | Option exercise | +400,000 | – | – | 1,898,048 |
| Jeffrey Nathan Sharpe Director | May 22, 2026 | Option exercise | +500,000 | – | – | 1,000,000 |
| Zbigniew Paul Lorenc Director | May 14, 2026 | Award | +11,175 | – | – | 433,323 |
| Capital Ventures LLC OnePointTwo 10% owner | May 12, 2026 | Buy | +422,500 | $0.80 | $338.00K | 1,047,500 |
| Lynn Sebastian Purcell Director, 10% owner | May 12, 2026 | Buy | +422,500 | $0.80 | $338.00K | 2,531,740 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 6 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Conexeu Sciences's stock actually held short. Settlement fails (shares not delivered on time) peaked at 86,695 shares on Oct 14, 2026 over the last 90 days.
See a number that looks wrong?